19-51225847-CCCGG-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001772.4(CD33):c.466_469delGGCC(p.Gly156fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0237 in 1,613,994 control chromosomes in the GnomAD database, including 576 homozygotes. Variant has been reported in ClinVar as Benign (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.016 ( 25 hom., cov: 31)
Exomes 𝑓: 0.025 ( 551 hom. )
Consequence
CD33
NM_001772.4 frameshift
NM_001772.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.86
Genes affected
CD33 (HGNC:1659): (CD33 molecule) Enables protein phosphatase binding activity and sialic acid binding activity. Involved in several processes, including negative regulation of cytokine production; negative regulation of monocyte activation; and positive regulation of protein tyrosine phosphatase activity. Located in several cellular components, including Golgi apparatus; external side of plasma membrane; and peroxisome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 19-51225847-CCCGG-C is Benign according to our data. Variant chr19-51225847-CCCGG-C is described in ClinVar as [Benign]. Clinvar id is 3024703.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0158 (2412/152196) while in subpopulation NFE AF= 0.026 (1770/68012). AF 95% confidence interval is 0.025. There are 25 homozygotes in gnomad4. There are 1043 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 25 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD33 | NM_001772.4 | c.466_469delGGCC | p.Gly156fs | frameshift_variant | 3/7 | ENST00000262262.5 | NP_001763.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD33 | ENST00000262262.5 | c.466_469delGGCC | p.Gly156fs | frameshift_variant | 3/7 | 1 | NM_001772.4 | ENSP00000262262.3 |
Frequencies
GnomAD3 genomes AF: 0.0159 AC: 2413AN: 152078Hom.: 25 Cov.: 31
GnomAD3 genomes
AF:
AC:
2413
AN:
152078
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0142 AC: 3561AN: 251316Hom.: 50 AF XY: 0.0138 AC XY: 1874AN XY: 135814
GnomAD3 exomes
AF:
AC:
3561
AN:
251316
Hom.:
AF XY:
AC XY:
1874
AN XY:
135814
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0245 AC: 35851AN: 1461798Hom.: 551 AF XY: 0.0236 AC XY: 17169AN XY: 727216
GnomAD4 exome
AF:
AC:
35851
AN:
1461798
Hom.:
AF XY:
AC XY:
17169
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0158 AC: 2412AN: 152196Hom.: 25 Cov.: 31 AF XY: 0.0140 AC XY: 1043AN XY: 74424
GnomAD4 genome
AF:
AC:
2412
AN:
152196
Hom.:
Cov.:
31
AF XY:
AC XY:
1043
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
CD33-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 17, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | CD33: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at